This inventor holds 1 USPTO granted patent. Top assignee: Ichnos Sciences Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Adam Drake and His Patent Work in Biotechnology.
Introduction
Adam Drake is an inventor associated with Neuchâtel, Switzerland, and Ichnos Sciences SA. His listed patent work concerns antibody-based biotechnology.
Latest Patents
Drake is associated with one patent, 1 patent: “CD3/BCMA/CD38 Trispecific Antibodies.” The title describes trispecific antibodies targeting CD3, BCMA, and CD38.
Career Highlights
The available information identifies Drake’s work with Ichnos Sciences SA and his contribution to the patent listed above. No further career details were provided.
Collaborations
Drake’s listed coworkers include Maria Pihlgren Bosch and Mario Perro.
Conclusion
Adam Drake’s recorded innovation activity centers on trispecific antibodies and his association with Ichnos Sciences SA in Neuchâtel, Switzerland.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile